Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon alpha treatment and thyroid dysfunction.

Yaron Tomer1, Jason T Blackard, Nagako Akeno

  • 1Division of Endocrinology, Cincinnati VA Medical Center, USA. yaron.tomer@uc.edu

Endocrinology and Metabolism Clinics of North America
|November 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PGM3-SCID: Differential impact of glycosylation on lymphocyte lineage development and function.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Chemical Profiling of Nyaope and Its Public Health Implications.

Toxics·2026
Same author

A Review of Human Immunodeficiency Virus and Hepatitis B Virus Co-Infection in Botswana.

Viruses·2026
Same author

The gut virome in children undergoing hematopoietic cell transplantation is diverse and a site for viral reactivation.

Bone marrow transplantation·2026
Same author

The HIV/HBV Co‑infection Paradox: Immune Modulation Amid Persistent Risk [Response To Letter].

Infection and drug resistance·2026
Same author

The Downregulation of Type 1 Diabetes Susceptibility Gene PGM1 Induces Metabolic Imbalance and Stress in Pancreatic β-Cells.

Diabetes·2026
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Hepatitis C patients on interferon therapy may develop thyroid disease. Interferon-induced thyroiditis (IIT) is linked to HCV, immune changes, direct thyroid effects, and genetics, requiring early detection.

Area of Science:

  • Endocrinology
  • Hepatology
  • Immunology

Background:

  • Interferon alpha (IFN alpha) is a primary treatment for chronic hepatitis C virus (HCV) infection.
  • HCV patients receiving IFN alpha have a significant risk of developing clinical thyroid disease (up to 15%) and thyroid antibodies (up to 40%).
  • IFN-induced thyroiditis (IIT) can necessitate treatment cessation, posing a clinical challenge.

Purpose of the Study:

  • To review the epidemiology and clinical manifestations of IIT.
  • To elucidate the mechanisms underlying IIT development.
  • To highlight the role of HCV in the pathogenesis of IIT.

Main Methods:

  • Review of prospective studies on IFN alpha therapy in HCV patients.
  • Analysis of data on thyroid dysfunction and antibody positivity.

Related Experiment Videos

  • Examination of proposed mechanisms of IIT, including immune modulation, direct toxicity, and genetic factors.
  • Main Results:

    • IIT can manifest as autoimmune thyroiditis (Hashimoto's, Graves') or nonautoimmune thyroiditis (destructive thyroiditis).
    • HCV infection itself contributes to thyroiditis development.
    • IFN alpha triggers thyroiditis through immune and direct toxic effects, with genetic predisposition playing a role.

    Conclusions:

    • IIT is a significant clinical issue in HCV patients treated with IFN alpha.
    • Understanding the multifactorial etiology of IIT is crucial for patient management.
    • Early detection and treatment of IIT are vital to prevent complications like cardiac arrhythmias.